Perito ER, Rodriguez LA, Lustig RH
Retatrutide targets GLP1 + GIP + glucagon, so some commentators have started calling it GLP3 to suggest a thirdgeneration medication. How Retatrutide Works: Triple Agonist Mechanism Retatrutide is being developed as a onceweekly injectable that activates GLP1, GIP, and glucagon receptors at the same time to influence appetite, blood sugar, and energy expenditure. GLP1 receptor activation Reduces appetite and food intake
The Imbalance Sources of free radical overproduction include mitochondria under duress, activated immune cells, and toxins
This is a great opportunity for us to introduce ourselves to those folks
119 The neuroprotective properties of GLP-1RAs have been substantiated in vivo, supported by their ability to traverse the blood-brain barrier and the presence of GLP-1 receptors within the brain